#immunology #rheumatology #InnovativeMedicine #jointhealth #JohnsonandJohnson #JandJ #JnJ #Tremfya #guselkumab #psoriaticarthritis #PsA #APEXtrial #activePsA #IL23blocker #pathogenesis #inflammatorydiseases #CD64receptor #CD64receptorbinder #IL23inhibitor #IL23treatment
pmlive.com/pharma_news/...
0
0
0
0